Abstracts
Copyright ©The Author(s) 2000. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Sep 15, 2000; 6(Suppl3): 127-127
Published online Sep 15, 2000. doi: 10.3748/wjg.v6.iSuppl3.127
Importance of hepatitis C as a risk factor for hepatocellular carcinoma in Guangxi
Zhuo-Lin Deng, Yun Ma, Ling Yuan, Pin-Kie Teng
Zhuo-Lin Deng, Yun Ma, Ling Yuan, Pin-Kie Teng, Department of Pathology, Guangxi Medical University, Nanning 530021, Guangxi Province, China
Author contributions: All authors contributed equally to the work.
Correspondence to: Dr. Zhuo-Lin Deng, Department of Pathology, Guangxi Medical University, Nanning 530021, China
Telephone: 771-5350477-8262
Received: December 22, 1999
Revised: March 24, 2000
Accepted: May 18, 2000
Published online: September 15, 2000
Abstract

AIM: To examine hepatitis C in hepatocellular carcinoma in most endemic area, Guangxi, China.

METHODS: Immunochemistry was performed on formalin fixed, paraffin embedded tissue sections. A total 202 specimens were analysed from the high, intermediate and low HCC prevalent regions of Guangxi.

RESULTS: The distribution of positive hepatitis C cases from high, intermediate and low regions was respectively 24/63 (38%), 23/62 (37%) and 30/77 (39%), with a total of 77/202 (38.12%).

CONCLUSION: Hepatitis C virus is an important risk factor in the development of hepatocellular carcinoma, but the regional difference in prevalence of this cancer is more likely influenced by hepatitis B viral infection and aflatoxin B1 exposure. In Guangxi, infection of hepatitis B and C virus in the development of hepatocellular carcinoma may be greatly enhanced by exposure to aflatoxin.

Keywords: Hepatitis C, Hepatoma, Risk factor, Immunohistochemistry, Gene, p53, Antibodies, monoclonal, Mutation